Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease
Georges Nakhoul(Cleveland Clinic), Sankar D. Navaneethan(Baylor College of Medicine), Jesse D. Schold(Colorado School of Public Health), Stacey E. Jolly(Cleveland Clinic), Joseph V. Nally(Cleveland Clinic), Haiquan Huang(Cleveland Clinic), Susana Arrigain(Cleveland Clinic)
Cited by 167
Related Papers
Heart Disease and Stroke Statistics—2021 Update
|Circulation|2021|5.7k
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure
|JAMA|2016|696
Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies
|The Lancet Diabetes & Endocrinology|2019|330
Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data
|Journal of the American Society of Nephrology|2019|209